Enliven Therapeutics, Inc.ELVNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-104M

-16.5% YoY

Free Cash Flow

$-70M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-25	-39↓56.7%	-84↓115.3%	-105↓25.2%	-120↓14.4%
Net Income	-25	-38↓52.2%	-72↓90.1%	-89↓24.4%	-104↓16.5%
EBITDA	-25	-39↓56.5%	-83↓115.8%	-104↓25.2%	-119↓14.5%
EPS Diluted	-3.17	-6.03↓90.2%	-2.01↑66.7%	-1.89↑6.0%	-1.83↑3.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	110	76↓31.3%	100↑32.6%	124↑23.9%	99↓20.3%
Total Current Assets	111	78↓29.7%	266↑242.3%	318↑19.5%	475↑49.3%
Total Assets	113	83↓26.5%	272↑226.4%	326↑19.8%	476↑46.2%
Total Current Liabilities	6	10↑68.9%	26↑166.5%	16↓38.5%	17↑4.1%
Total Liabilities	6	160↑2376.0%	26↓83.8%	16↓38.7%	17↑4.8%
Total Equity	107	-77↓171.9%	246↑420.1%	310↑26.0%	460↑48.3%
Total Debt	0	0↑103.1%	0↑3.7%	0	0
Net Debt	-110	-75↑31.5%	-100↓32.7%	-124↓24.4%	-98↑20.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-19	-32↓67.6%	-61↓91.0%	-73↓19.5%	-70↑3.9%
Capital Expenditure	-0	-1↓220.4%	-0↑75.7%	-0↑70.5%	-0↓259.1%
Free Cash Flow	-19	-33↓69.2%	-61↓87.9%	-73↓19.2%	-70↑3.8%
Stock-Based Comp	2	3↑65.9%	13↑304.7%	20↑56.2%	34↑68.6%
Net Change in Cash	-20	-34↓69.5%	25↑171.3%	24↓2.6%	-25↓205.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance